Menstrual Wellbeing in Woman Living in Turkey; an Epidemiological Study

Sponsor

Dr. Lutfi Kirdar Kartal Training and Research Hospital (Other)

Overall Status

Completed

CT.gov ID

NCT05442541

Collaborator

Turkish Endometriosis and Adenomyosis Society (Other), IPSOS Group S.A (Other)

1,829

Enrollment

Location

Actual Duration (Months)

1795.8

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Women with endometriosis in our country and around the world face various difficulties during their menstrual periods in reproductive age. While some of these difficulties are caused by the environment, some of them are due to the insufficient development of personal consciousness. In our study, we aim to reveal the perspective of individuals and society on the menstrual period. Our primary aim in our study is to understand what kind of problems are experienced in different regions of our country during the menstrual period for women and how they are spent. Secondly, the effect of this period on women's quality of life will be examined.

Condition or Disease	Intervention/Treatment	Phase
Menstrual Problem Quality of Life	Behavioral: not included any interventions(Evaluation of menstrual well-being in women of reproductive age, field survey study)

Detailed Description

Our research will be conducted between January 1, 2022, and February 1, 2022, in 7 different regions of our country, by asking questions to women of reproductive age from different groups. Each participant will be asked to answer the survey questions and the results will be analyzed. The survey will be done face to face. The questionnaire contains questions about women's socio-demographic data, their perspectives on their menstrual period, their information about endometriosis, and their perspectives on pads and birth control pills. Menstruating women of reproductive age between the ages of 18- 45 will be included in this study. As a result of the study, the problems experienced by women of reproductive age in different regions will be evaluated.

Study Design

Study Type:

Observational [Patient Registry]

Actual Enrollment :

1829 participants

Observational Model:

Other

Time Perspective:

Prospective

Official Title:

Üreme çağındaki kadınlarda menstrüel Iyilik Halinin değerlendirilmesi Saha Anket çalışması/Evaluation of Menstrual Well-being in Women of Reproductive Age, Field Survey Study

Actual Study Start Date :

Jan 1, 2022

Actual Primary Completion Date :

Feb 1, 2022

Actual Study Completion Date :

Feb 1, 2022

Outcome Measures

Primary Outcome Measures

Disparities in menstrual hygiene and well-being between 7 regions of Turkey in women of reproductive age with a questionnaire [1 month]
In this study, the effect of the menstrual period on the quality of life of 1829 women living in seven different geographical regions of our country will be examined through a questionnaire. The goal of this study is to evaluate the menstrual well-being of women living in different regions of our country.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years to 45 Years

Sexes Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Menstruating women of reproductive age between the ages of 18- 45 will be included in this study.

Exclusion Criteria:

Women with a history of hematological disease, cardiovascular disease, malignancy, advanced renal failure, active infection, diabetes mellitus, and pregnant women will not be included in the study.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Kartal Dr. Lutfi Kirdar Research and Training Hospital	Istanbul		Turkey

Sponsors and Collaborators

Dr. Lutfi Kirdar Kartal Training and Research Hospital
Turkish Endometriosis and Adenomyosis Society
IPSOS Group S.A

Investigators

Study Director: Ahmet Kale, Prof.Dr., Kartal Dr. Lutfi Kirdar Research and Training Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Elif Cansu Gundogdu, Principal Investigator, Dr. Lutfi Kirdar Kartal Training and Research Hospital

ClinicalTrials.gov Identifier:

NCT05442541

Other Study ID Numbers:

2021/514/216/15

First Posted:

Jul 5, 2022

Last Update Posted:

Jul 5, 2022

Last Verified:

Jun 1, 2022

Individual Participant Data (IPD) Sharing Statement:

Undecided

Plan to Share IPD:

Undecided

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Keywords provided by Elif Cansu Gundogdu, Principal Investigator, Dr. Lutfi Kirdar Kartal Training and Research Hospital

Additional relevant MeSH terms:

Menstruation Disturbances

Study Results

No Results Posted as of Jul 5, 2022